Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. ILMN

Market Cap: $31.24B

II

Illumina, Inc.

ILMN
NASDAQ (NASDAQ Global Select)USD
Purchase ILMN
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin66.79%
EBITDA Margin30.34%
EBIT Margin24.26%
Pre-tax Margin22.59%
Net Profit Margin18.36%
Earnings Yield2.65%
Valuation Multiples
Price / Book10.98
Price / Sales6.95
Price / Earnings38.16
PEG-1.20
Forward PEG2.80
EV / Sales7.28
EV / EBITDA24.01
EV / Operating Cash Flow29.88
EV / Free Cash Flow34.85
Price / Free Cash Flow33.27
Price / Operating Cash Flow28.47
Cash Flow & Capital
Free Cash Flow / Share$6.22
Operating Cash Flow / Share$7.25
Free Cash Flow Yield3.01%
Capex / Revenue3.47%
Capex / Operating Cash Flow14.25%
Capex / Depreciation1.16
Stock Compensation / Revenue1.56%
Dividend Payout Ratio0.00%
Dividend Yield0.00%
Liquidity & Leverage
Current Ratio1.80
Quick Ratio1.40
Cash Ratio0.66
Debt / Assets0.38
Debt / Capital0.47
Debt / Equity0.89
Long-Term Debt / Capital0.34
Debt / Market Cap6.37%
Net Debt / EBITDA1.09
Solvency Ratio0.29
Financial Leverage2.34
Efficiency & Working Capital
Asset Turnover0.68
Fixed Asset Turnover4.06
Inventory Turnover2.37
Receivables Turnover5.88
Payables Turnover6.49
Days Sales Outstanding62.07
Days Inventory Outstanding153.88
Days Payables Outstanding56.27
Operating Cycle215.94
Cash Conversion Cycle159.68
Working Capital Turnover3.70
Returns & Quality
Return on Equity31.08%
Return on Assets12.41%
Return on Invested Capital13.54%
ROCE18.57%
Return on Tangible Assets16.65%
Operating Return on Assets14.26%
Income Quality2.26
Tax Burden0.81
Interest Burden0.93
Balance Sheet & Intrinsic Metrics
Enterprise Value$32.72B
Invested Capital$4.06B
Working Capital$1.26B
Tangible Asset Value$1.14B
Net Current Asset Value$-978M
Graham Number$48.07
Graham Net-Net-$11.63
Book Value / Share$18.79
Tangible Book Value / Share$7.58
Cash / Share$7.74
Financial Health Scores
Piotroski Score6
Altman Z-Score6.23
Revenue$4.49B
EBIT$1.09B
Market Cap$30.45B
Working Capital$1.26B
Retained Earnings$-51M
Total Assets$6.65B
Total Liabilities$3.81B